Establishing the cascade of care for hepatitis C in England-benchmarking to monitor impact of direct acting antivirals
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Establishing the cascade of care for hepatitis C in England-benchmarking to monitor impact of direct acting antivirals
Authors
Keywords
-
Journal
JOURNAL OF VIRAL HEPATITIS
Volume 25, Issue 5, Pages 482-490
Publisher
Wiley
Online
2017-12-14
DOI
10.1111/jvh.12844
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
- (2016) Natasha K. Martin et al. JOURNAL OF HEPATOLOGY
- New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England
- (2016) R. J. Harris et al. JOURNAL OF VIRAL HEPATITIS
- Clinical Care Pathways for Patients With Hepatitis C: Reducing Critical Barriers to Effective Treatment
- (2016) Nik Howes et al. Open Forum Infectious Diseases
- Hepatitis C virus treatment as prevention among injecting drug users: who should we cure first?
- (2015) Anneke S. de Vos et al. ADDICTION
- Correlates of Initiation of Treatment for Chronic Hepatitis C Infection in United States Veterans, 2004–2009
- (2015) Adi V. Gundlapalli et al. PLoS One
- Rate, Delay and Predictors of Hepatitis C Treatment in British Columbia
- (2015) Alan Hoi Lun Yau et al. Canadian Journal of Gastroenterology and Hepatology
- Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality
- (2014) Matthew E Cramp et al. BMC GASTROENTEROLOGY
- Increased uptake and new therapies are needed to avert rising hepatitis C-related end stage liver disease in England: Modelling the predicted impact of treatment under different scenarios
- (2014) Ross J. Harris et al. JOURNAL OF HEPATOLOGY
- HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact
- (2014) N. K. Martin et al. JOURNAL OF VIRAL HEPATITIS
- Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy
- (2013) Natasha K. Martin et al. CLINICAL INFECTIOUS DISEASES
- Using surveillance data to determine treatment rates and outcomes for patients with chronic hepatitis C virus infection
- (2013) Sam Lattimore et al. HEPATOLOGY
- Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons
- (2013) Natasha K Martin et al. BMJ Open
- Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis
- (2011) Ross J. Harris et al. EUROPEAN JOURNAL OF PUBLIC HEALTH
- Importance of Patient, Provider and Facility Predictors of Hepatitis C Virus Treatment in Veterans: A National Study
- (2010) Jennifer R Kramer et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility
- (2010) Natasha K. Martin et al. JOURNAL OF HEPATOLOGY
- Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents
- (2009) J. Grebely et al. JOURNAL OF VIRAL HEPATITIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started